Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegIntron Plus Ribavirin for Chronic Hepatitis C in HIV-Infected Persons
NCT00687544Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- Dec 2005
- Primary completion
- Sep 2008
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands, Cytokines & Interferons
01
Overview
A Phase 4 trial of peginterferon alfa-2b, ribavirin in chronic hepatitis C (CHC), sponsored by Merck & Co.. Started Dec 2005; status: terminated.
02
Drugs
peginterferon alfa-2bribavirin
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT00687544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687544.